Plasma p-tau assay highly accurate in identifying Alzheimer’s-related pathology

A plasma phosphorylated-tau217 assay demonstrated a high degree of accuracy in identifying biomarkers consistent with Alzheimer’s disease-related pathology, according to research from JAMA Neurology.
“Blood biomarkers have emerged as scalable tools for clinical evaluation, trial recruitment and disease monitoring,” Nicholas J. Ashton, PhD, a researcher in the department of psychiatry and neurochemistry at the Institute of Neuroscience and Physiology at Sahlgrenska Academy in the University of Gothenburg, and colleagues wrote. “Phosphorylated tau is the leading blood

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.